Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001805688-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | A - Grant | $0.00 | +9,782 | 52.8K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-26 | A | A | 9,782 | $0.00 | 52,775 | D | — | — |